Skip to main content
Equibles
PG logo

PG · PROCTER & GAMBLE Co · Debt

Track PG — free

Use PG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$161.02 -4.57 (-2.76%) At close · Oct 23
Ex-dividend: $1.0885 · Oct 23, 2026 Return incl. dividend (before tax) -2.10%
S&P 500 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$373.21B
Shares
2.32B
Volume · Oct 23 10.35M Avg daily vol (3M) 9.18M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Latest reported total
USD 34,700,000,000
As of Jun 30, 2020
Tracked instruments
28
Loans, facilities and note series
Annual baseline
Jun 30, 2020
Latest approved annual total
Reported total debt history
As of Reported label Amount Source
2020-06-30 Total debt USD 34,700,000,000 10-K/A filed 2020-08-07
Total debt was $34.7 billion as of June 30, 2020 and $30.1 billion as of June 30, 2019. The increase is primarily due to the issuance of bonds generating $5.0 billion of cash.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current debt and lease obligations 2026-09-30 USD 17,028,000,000 10-Q filed 2026-10-22
Noncurrent debt carrying amount 2026-09-30 USD 21,897,000,000 10-Q filed 2026-10-22
3 filing observations remain unmatched and are excluded from instrument histories.
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
2 filings have incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

2.450% Notes due March 25, 2025

Note · The Procter & Gamble Company

Reference: 2.450% Notes due March 25, 2025

Active
Original principal
USD 750,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Mar 25, 2025

Last reported interest terms: 2.45% Reported 2020-03-26 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2020-03-25 Original principal USD 750,000,000 Exact source document Parent 8-K filing · 2020-03-26
    On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

0.550% Notes due October 29, 2025

Note · The Procter & Gamble Company

Reference: 0.550% Notes due October 29, 2025

Active
Original principal
USD 1,000,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Oct 29, 2025

Last reported interest terms: 0.55% Reported 2020-10-29 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2020-10-29 Original principal USD 1,000,000,000 Exact source document Parent 8-K filing · 2020-10-29
    On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

1.000% Notes due April 23, 2026

Note · The Procter & Gamble Company

Reference: 1.000% Notes due April 23, 2026

Active
Original principal
USD 1,000,000,000
Outstanding
USD 1,000,000,000
Commitment
—
Availability
—
Maturity
Apr 23, 2026

Last reported interest terms: 1% Reported 2021-04-23 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2021-04-23 Original principal USD 1,000,000,000 Outstanding USD 1,000,000,000 Exact source document Parent 8-K filing · 2021-04-23
    On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

3.250% Notes due August 2, 2026

Note · The Procter & Gamble Company

Reference: 3.250% Notes due August 2, 2026

Active
Original principal
EUR 650,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Aug 2, 2026

Last reported interest terms: 3.25% Reported 2023-05-02 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2023-05-02 Original principal EUR 650,000,000 Exact source document Parent 8-K filing · 2023-05-02
    On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

1.900% Notes due February 1, 2027

Note · The Procter & Gamble Company

Reference: 1.900% Notes due February 1, 2027

Active
Original principal
USD 1,000,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Feb 1, 2027

Last reported interest terms: 1.9% Reported 2022-02-01 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2022-02-01 Original principal USD 1,000,000,000 Exact source document Parent 8-K filing · 2022-02-01
    On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

2.800% Notes due March 25, 2027

Note · The Procter & Gamble Company

Reference: 2.800% Notes due March 25, 2027

Active
Original principal
USD 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Mar 25, 2027

Last reported interest terms: 2.8% Reported 2020-03-26 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2020-03-25 Original principal USD 500,000,000 Exact source document Parent 8-K filing · 2020-03-26
    On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

3.150% Notes due April 29, 2028

Note · The Procter & Gamble Company

Reference: 3.150% Notes due April 29, 2028

Active
Original principal
EUR 650,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Apr 29, 2028

Last reported interest terms: 3.15% Reported 2024-04-29 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2024-04-29 Original principal EUR 650,000,000 Exact source document Parent 8-K filing · 2024-04-29
    On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Issuer evidence: On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Supporting evidence: On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

4.350% Notes due January 29, 2029

Note · The Procter & Gamble Company

Reference: 4.350% Notes due January 29, 2029

Active
Original principal
USD 600,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Jan 29, 2029

Last reported interest terms: 4.35% Reported 2024-01-29 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2024-01-29 Original principal USD 600,000,000 Exact source document Parent 8-K filing · 2024-01-29
    On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Issuer evidence: On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Supporting evidence: On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

4.150% Notes due October 24, 2029

Note · The Procter & Gamble Company

Reference: 4.150% Notes due October 24, 2029

Active
Original principal
USD 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Oct 24, 2029

Last reported interest terms: 4.15% Reported 2024-10-24 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2024-10-24 Original principal USD 500,000,000 Exact source document Parent 8-K filing · 2024-10-24
    On October 24, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.150% Notes due October 24, 2029 and $500,000,000 aggregate principal amount of 4.550% Notes due October 24, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Issuer evidence: On October 24, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.150% Notes due October 24, 2029 and $500,000,000 aggregate principal amount of 4.550% Notes due October 24, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

3.000% Notes due March 25, 2030

Note · The Procter & Gamble Company

Reference: 3.000% Notes due March 25, 2030

Active
Original principal
USD 1,500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Mar 25, 2030

Last reported interest terms: 3% Reported 2020-03-26 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2020-03-25 Original principal USD 1,500,000,000 Exact source document Parent 8-K filing · 2020-03-26
    On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

4.050% Notes due May 1, 2030

Note · The Procter & Gamble Company

Reference: 4.050% Notes due May 1, 2030

Active
Original principal
USD 700,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
May 1, 2030

Last reported interest terms: 4.05% Reported 2025-05-01 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2025-05-01 Original principal USD 700,000,000 Exact source document Parent 8-K filing · 2025-05-01
    On May 1, 2025, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $700,000,000 aggregate principal amount of 4.050% Notes due May 1, 2030 and $550,000,000 aggregate principal amount of 4.600% Notes due May 1, 2035 under the Company's Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On May 1, 2025, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $700,000,000 aggregate principal amount of 4.050% Notes due May 1, 2030 and $550,000,000 aggregate principal amount of 4.600% Notes due May 1, 2035 under the Company's Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

0.350% Notes due May 5, 2030

Note · The Procter & Gamble Company

Reference: 0.350% Notes due May 5, 2030

Active
Original principal
EUR 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
May 5, 2030

Last reported interest terms: 0.35% Reported 2021-11-05 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2021-11-05 Original principal EUR 500,000,000 Exact source document Parent 8-K filing · 2021-11-05
    On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).
    Issuer evidence: On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).
    Supporting evidence: On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).

1.200% Notes due October 29, 2030

Note · The Procter & Gamble Company

Reference: 1.200% Notes due October 29, 2030

Active
Original principal
USD 1,250,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Oct 29, 2030

Last reported interest terms: 1.2% Reported 2020-10-29 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2020-10-29 Original principal USD 1,250,000,000 Exact source document Parent 8-K filing · 2020-10-29
    On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

1.950% Notes due April 23, 2031

Note · The Procter & Gamble Company

Reference: 1.950% Notes due April 23, 2031

Active
Original principal
USD 1,000,000,000
Outstanding
USD 1,000,000,000
Commitment
—
Availability
—
Maturity
Apr 23, 2031

Last reported interest terms: 1.95% Reported 2021-04-23 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2021-04-23 Original principal USD 1,000,000,000 Outstanding USD 1,000,000,000 Exact source document Parent 8-K filing · 2021-04-23
    On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

3.250% Notes due August 2, 2031

Note · The Procter & Gamble Company

Reference: 3.250% Notes due August 2, 2031

Active
Original principal
EUR 650,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Aug 2, 2031

Last reported interest terms: 3.25% Reported 2023-05-02 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2023-05-02 Original principal EUR 650,000,000 Exact source document Parent 8-K filing · 2023-05-02
    On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

2.300% Notes due February 1, 2032

Note · The Procter & Gamble Company

Reference: 2.300% Notes due February 1, 2032

Active
Original principal
USD 850,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Feb 1, 2032

Last reported interest terms: 2.3% Reported 2022-02-01 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2022-02-01 Original principal USD 850,000,000 Exact source document Parent 8-K filing · 2022-02-01
    On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

4.550% Notes due January 29, 2034

Note · The Procter & Gamble Company

Reference: 4.550% Notes due January 29, 2034

Active
Original principal
USD 750,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Jan 29, 2034

Last reported interest terms: 4.55% Reported 2024-01-29 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2024-01-29 Original principal USD 750,000,000 Exact source document Parent 8-K filing · 2024-01-29
    On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Issuer evidence: On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Supporting evidence: On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

3.200% Notes due April 29, 2034

Note · The Procter & Gamble Company

Reference: 3.200% Notes due April 29, 2034

Active
Original principal
EUR 850,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Apr 29, 2034

Last reported interest terms: 3.2% Reported 2024-04-29 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2024-04-29 Original principal EUR 850,000,000 Exact source document Parent 8-K filing · 2024-04-29
    On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Issuer evidence: On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Supporting evidence: On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

4.550% Notes due October 24, 2034

Note · The Procter & Gamble Company

Reference: 4.550% Notes due October 24, 2034

Active
Original principal
USD 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Oct 24, 2034

Last reported interest terms: 4.55% Reported 2024-10-24 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2024-10-24 Original principal USD 500,000,000 Exact source document Parent 8-K filing · 2024-10-24
    On October 24, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.150% Notes due October 24, 2029 and $500,000,000 aggregate principal amount of 4.550% Notes due October 24, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Issuer evidence: On October 24, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.150% Notes due October 24, 2029 and $500,000,000 aggregate principal amount of 4.550% Notes due October 24, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

4.600% Notes due May 1, 2035

Note · The Procter & Gamble Company

Reference: 4.600% Notes due May 1, 2035

Active
Original principal
USD 550,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
May 1, 2035

Last reported interest terms: 4.6% Reported 2025-05-01 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2025-05-01 Original principal USD 550,000,000 Exact source document Parent 8-K filing · 2025-05-01
    On May 1, 2025, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $700,000,000 aggregate principal amount of 4.050% Notes due May 1, 2030 and $550,000,000 aggregate principal amount of 4.600% Notes due May 1, 2035 under the Company's Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On May 1, 2025, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $700,000,000 aggregate principal amount of 4.050% Notes due May 1, 2030 and $550,000,000 aggregate principal amount of 4.600% Notes due May 1, 2035 under the Company's Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

3.550% Notes due March 25, 2040

Note · The Procter & Gamble Company

Reference: 3.550% Notes due March 25, 2040

Active
Original principal
USD 1,000,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Mar 25, 2040

Last reported interest terms: 3.55% Reported 2020-03-26 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2020-03-25 Original principal USD 1,000,000,000 Exact source document Parent 8-K filing · 2020-03-26
    On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

0.900% Notes due November 4, 2041

Note · The Procter & Gamble Company

Reference: 0.900% Notes due November 4, 2041

Active
Original principal
EUR 600,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Nov 4, 2041

Last reported interest terms: 0.9% Reported 2021-11-05 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2021-11-05 Original principal EUR 600,000,000 Exact source document Parent 8-K filing · 2021-11-05
    On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).
    Issuer evidence: On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).
    Supporting evidence: On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).

3.600% Notes due March 25, 2050

Note · The Procter & Gamble Company

Reference: 3.600% Notes due March 25, 2050

Active
Original principal
USD 1,250,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Mar 25, 2050

Last reported interest terms: 3.6% Reported 2020-03-26 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2020-03-25 Original principal USD 1,250,000,000 Exact source document Parent 8-K filing · 2020-03-26
    On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).
    Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Floating Rate Notes due November 16, 2070

Note · The Procter & Gamble Company

Reference: Floating Rate Notes due November 16, 2070

Active
Original principal
USD 197,067,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Nov 16, 2070

Last reported interest terms: Floating Rate Reported 2020-11-16 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2020-11-16 Original principal USD 197,067,000 Exact source document Parent 8-K filing · 2020-11-16
    On November 16, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $197,067,000 aggregate principal amount of Floating Rate Notes due November 16, 2070 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On November 16, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $197,067,000 aggregate principal amount of Floating Rate Notes due November 16, 2070 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On November 16, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $197,067,000 aggregate principal amount of Floating Rate Notes due November 16, 2070 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Floating Rate Notes due February 8, 2072

Note · The Procter & Gamble Company

Reference: Floating Rate Notes due February 8, 2072

Active
Original principal
USD 412,533,000
Outstanding
USD 412,533,000
Commitment
—
Availability
—
Maturity
Feb 8, 2072

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2022-02-08 Original principal USD 412,533,000 Outstanding USD 412,533,000 Exact source document Parent 8-K filing · 2022-02-08
    On February 8, 2022, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $412,533,000 aggregate principal amount of Floating Rate Notes due February 8, 2072 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545).
    Issuer evidence: On February 8, 2022, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $412,533,000 aggregate principal amount of Floating Rate Notes due February 8, 2072 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545).
    Supporting evidence: On February 8, 2022, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $412,533,000 aggregate principal amount of Floating Rate Notes due February 8, 2072 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545).

Floating Rate Notes due February 3, 2073

Note · The Procter & Gamble Company

Reference: Floating Rate Notes due February 3, 2073

Active
Original principal
USD 482,886,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Feb 3, 2073

Last reported interest terms: Floating Rate Notes due February 3, 2073 Reported 2023-02-03 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2023-02-03 Original principal USD 482,886,000 Exact source document Parent 8-K filing · 2023-02-03
    On February 3, 2023, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $482,886,000 aggregate principal amount of Floating Rate Notes due February 3, 2073 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Issuer evidence: On February 3, 2023, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $482,886,000 aggregate principal amount of Floating Rate Notes due February 3, 2073 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.
    Supporting evidence: On February 3, 2023, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $482,886,000 aggregate principal amount of Floating Rate Notes due February 3, 2073 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Floating Rate Notes due November 1, 2073

Note · The Procter & Gamble Company

Reference: Floating Rate Notes due November 1, 2073

Active
Original principal
USD 256,534,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Nov 1, 2073

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2023-11-01 Original principal USD 256,534,000 Exact source document Parent 8-K filing · 2023-11-01
    On November 1, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $256,534,000 aggregate principal amount of Floating Rate Notes due November 1, 2073 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Issuer evidence: On November 1, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $256,534,000 aggregate principal amount of Floating Rate Notes due November 1, 2073 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Supporting evidence: On November 1, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $256,534,000 aggregate principal amount of Floating Rate Notes due November 1, 2073 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Floating Rate Notes due November 4, 2075

Note · The Procter & Gamble Company

Reference: Floating Rate Notes due November 4, 2075

Active
Original principal
USD 258,889,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Nov 4, 2075

Last reported interest terms: Floating Rate Notes Reported 2025-11-04 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2025-11-04 Original principal USD 258,889,000 Exact source document Parent 8-K filing · 2025-11-04
    On November 4, 2025, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $258,889,000 aggregate principal amount of Floating Rate Notes due November 4, 2075 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
    Issuer evidence: On November 4, 2025, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $258,889,000 aggregate principal amount of Floating Rate Notes due November 4, 2075 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).
Key facts CIK 80424 CUSIP 742718109 13F (30d) 1371 filings 1332 filers Visit website Investor relations